News
Company News
Industry Insights
Industry Insights
Home > News
-
Wecare’s 120+ Global Multi-Center Clinical Trials: Core E-E-A-T Advantage for Probiotic GlobalizationMay 06 MORE > -
Wecare-Agri Agricultural Microbes: Low-Carbon Soil & Crop Microecology Solutions for Global FarmsJune 17 MORE > -
LBPs CRDMO Full-Service: Wecare-Pharm’s Clinical & Manufacturing Advantages for Global BiotechsJune 10 MORE > -
AI+MBT Microbial Biomanufacturing: Wecare’s Breakthrough for Global Probiotic R&DJune 03 MORE > -
What Are the Most Clinically Studied Probiotic Strains for GLP-1?May 27 MORE > -
Asia/China Top 1 Weizmannia (Bacillus) coagulans BC99 Strain Manufacturer & Probiotics FactoryWecare Probiotics is Asia's No.1 Bacillus coagulans manufacturer with 200T annual BC99 capacity (>90% China market share). 300B CFU/g, 150°C heat resistance, 10+ clinical trials, FDA GRAS. Trusted CDMO for global brands.April 23 MORE >
No.999,Guangming Rd., Wujiang Economic and Technological Development Zone, Suzhou City, Jiangsu Province, China
Leave a Message
Email
Linkedin